ArticleNucleic acid therapeutics2018

Development of Locked Nucleic Acid Antisense Oligonucleotides Targeting Ebola Viral Proteins and Host Factor Niemann-Pick C1.

Jessica Chery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.